In powers and duties of the Department of State and its departmental administrative board, establishing the Pharmaceutical Collection Sites Educational Program.
Impact
If enacted, HB 818 would significantly update the framework for pharmaceutical waste management within the state. By providing pharmaceutical facilities with educational resources and financial support—specifically a continued appropriation of $2 million from the General Fund—the legislation could enhance the state's efforts in combating drug-related issues, including improper disposal and access to prescription medications by unauthorized individuals. This financial backing would ensure that pharmacies are adequately equipped to comply with federal and state regulations regarding pharmaceutical disposal.
Summary
House Bill 818 aims to establish a Pharmaceutical Collection Sites Educational Program under the Pennsylvania Department of State. This program is designed to educate pharmacies on their capacity to adjust their registration with the United States Drug Enforcement Administration (DEA) to facilitate the receipt and destruction of mail-back packages and to manage collection receptacles for prescription drugs. The initiative addresses the critical issue of prescription drug safety and the need for proper disposal methods to reduce drug abuse and environmental hazards.
Sentiment
The sentiment surrounding the bill appears to be broadly supportive among health advocates, pharmacy professionals, and some legislative members. They view the initiative as a necessary step towards improving public health and safety by creating more proactive drug take-back options. However, there may be concerns regarding the implementation of the program, particularly regarding the effectiveness of educational outreach and whether the funding will be sufficient to achieve its goals.
Contention
Despite its largely positive reception, some critics may raise questions regarding the use of state funds for the initiative and whether the program will have adequate oversight and evaluation measures to ensure its success. Additionally, there may be concerns about the program's reach and whether it can effectively address the needs of smaller pharmacies, which might lack the resources or infrastructure to adequately participate in such a program. Overall, the discussion highlights the importance of collaboration between state agencies and health care providers.
In powers and duties of the Department of State and its departmental administrative board, establishing the Pharmaceutical Collection Sites Educational Program.
In powers and duties of the Department of Public Instruction and its departmental administrative boards and commissions, further providing for collective bargaining.
In administrative organization, further providing for advisory boards and commissions; and, in powers and duties of the Department of Health and its departmental administrative and advisory boards, establishing the Brain Injury Advisory Board.
In powers and duties of the Department of Labor and Industry, its departmental administrative and advisory boards and departmental administrative officers, further providing for Elevator Safety Board.
In powers and duties of the Department of Health and its departmental administrative and advisory boards, providing for perimenopause and menopause education.
In powers and duties of the Department of Health and its departmental administrative and advisory boards, providing for pelvic floor dysfunction education.
In powers and duties of the Department of General Services and its departmental administrative and advisory boards and commissions, providing for menstrual hygiene products in State buildings.
In powers and duties of the Department of General Services and its departmental administrative and advisory boards and commissions, providing for menstrual hygiene products in State buildings.
In powers and duties of the Department of Health and its departmental administrative and advisory boards, providing for perimenopause and menopause education.